Episodes 61-75 of 795
Head-to-head comparison of two TAVR devices in patients with aortic stenosis and small aortic annuli
ACC Action CenterHead-to-head comparison of two TAVR devices in patients with aortic stenosis and small aortic annuli
APOC3 ASO significantly lowers triglycerides in patients with hypertriglyceridemia and high CV risk
ACC Action CenterAPOC3 ASO significantly lowers triglycerides in patients with hypertriglyceridemia and high CV risk
No improvements in CV outcomes at 90 days with human ApoA-1 infusions post-MI
ACC Action CenterNo improvements in CV outcomes at 90 days with human ApoA-1 infusions post-MI
Early aggressive lipid-lowering strategy with PCSK9 siRNA performs better than usual care in US patients with ASCVD
ACC Action CenterEarly aggressive lipid-lowering strategy with PCSK9 siRNA performs better than usual care in US patients with ASCVD
No effect on the primary endpoint with SGLT2i post-MI, but significant effect on HF hospitalizations
ACC Action CenterNo effect on the primary endpoint with SGLT2i post-MI, but significant effect on HF hospitalizations
Allergic Reactions and Cardiac Concerns: Exploring the Heart Disease Link
Heart MattersAllergic Reactions and Cardiac Concerns: Exploring the Heart Disease Link
Active Aging: Preventing Heart Failure in Older Women with Exercise
Heart MattersActive Aging: Preventing Heart Failure in Older Women with Exercise
Improving CKD Patient Outcomes with SGLT2 Inhibitors
Clinician's RoundtableImproving CKD Patient Outcomes with SGLT2 Inhibitors
Cardiovascular Disease in T2D: Researchers Identify Potential Therapeutic Target for Underlying Cause
Heart MattersCardiovascular Disease in T2D: Researchers Identify Potential Therapeutic Target for Underlying Cause
New Guidance on Neurodevelopment Outcomes in Patients with Heart Defects
Heart MattersNew Guidance on Neurodevelopment Outcomes in Patients with Heart Defects
AHA Identifies CKM Syndrome: A First Step in Managing Patients with CVD
Heart MattersAHA Identifies CKM Syndrome: A First Step in Managing Patients with CVD
CKM Syndrome Linked to Heart, Kidney, and Metabolic Diseases
Heart MattersCKM Syndrome Linked to Heart, Kidney, and Metabolic Diseases
Pharmacist-Prescribing and Hypertension Management: An Economic Benefit
Heart MattersPharmacist-Prescribing and Hypertension Management: An Economic Benefit
SELECT Trial: Semaglutide Lowers CVD Risk in Patients with Obesity
Heart MattersSELECT Trial: Semaglutide Lowers CVD Risk in Patients with Obesity
